2007
DOI: 10.4158/ep.13.6.601
|View full text |Cite
|
Sign up to set email alerts
|

Novel Endocrine Disrupter Effects of Classic and Atypical Antipsychotic Agents and Divalproex: Induction of Adrenal Hyperandrogenism, Reversible with Metformin or Rosiglitazone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(15 citation statements)
references
References 19 publications
1
14
0
Order By: Relevance
“…In the case of psychiatric disorders, such as schizophrenia, therapeutic strategies that target the underlying metabolic dysfunction could provide an effective alternative to traditional antipsychotic medications 87 . This possibility is supported by the finding that the insulin-sensitizing agents metformin and rosiglitazone can correct the insulin resistance that seems to come hand in hand with antipsychotic treatment without inhibiting the antipsychotic drug efficacy in treating the disease 105 .…”
Section: Therapeutic Implicationssupporting
confidence: 56%
“…In the case of psychiatric disorders, such as schizophrenia, therapeutic strategies that target the underlying metabolic dysfunction could provide an effective alternative to traditional antipsychotic medications 87 . This possibility is supported by the finding that the insulin-sensitizing agents metformin and rosiglitazone can correct the insulin resistance that seems to come hand in hand with antipsychotic treatment without inhibiting the antipsychotic drug efficacy in treating the disease 105 .…”
Section: Therapeutic Implicationssupporting
confidence: 56%
“…This suggests that schizophrenia patients with high levels of insulin might benefit from coadministration of insulin-sensitizing agents. Along these lines, the drugs metformin and rosiglitazone have been administered in clinical studies to correct the antipsychotic-induced insulin resistance that is typically associated with this class of drugs (Bahtiyar et al, 2007).…”
Section: Personalized Medicine Approaches Using Circulating Biomarkersmentioning
confidence: 99%
“…The latter two groups of anti-retroviral drugs have also been associated with adrenal hyperplasia (Sacerdote, 2006). In our study we found that metformin corrected adrenal hyperandrogenism in 8/8 patients and rosiglitazone corrected adrenal hyperandrogenism in 2/2 patients on anti-psychotic drugs and/or valproate (Bahtiyar, 2007). (Figures 3 and 4).…”
Section: Metformin or Rosiglitazone In The Psychotropic/valproate-indmentioning
confidence: 78%
“…In Arit's study four of 203 patients with CAH had forms of NCAH other than 21-hydroxylase deficiency (Arit et al, 2010). We studied 26 consecutive, non-selected psychiatric patients taking classical anti-psychotic agents, atypical anti-psychotic agents, and/or valproate and we noted that all 26 had adrenal hyperandrogenemia; 2 had biochemical evidence of 21-hydroxylase deficiency, 8 of 3--ol-dehydrogenase deficiency, four of 11-hydroxylase deficiency, and two of aldosterone synthase deficiency (Bahtiyar et al, 2007). All of the above psychotropic agents cause insulin resistance and 10/10 patients who took an insulin sensitizer normalized biochemically.…”
Section: Other Forms Of Non-classical Cah Associated With Insulin Resmentioning
confidence: 99%